• 凯发K8

    Advanced vector design and manufacturing and gene
    PackRV-SS® vector technology & eVLP gene editing delivery technology: the leading innovators.
    GMP-grade retroviral vector (RVV) global CRO/CDMO
    China's only GMP-certified industrial-scale RVV production platform.

    Cells benefit living organisms

    Genes create the future

    Cell Valley Group was co-founded by American and Hong Kong Chinese scientists from top universities such as Harvard and Cornell.  Leveraging cutting-edge research expertise, the group has established three core centers and five wholly-owned subsidiaries in South and North China, operating over 10,000 square meters of GMP workshops and international standard laboratories. Its core technologies lead the industry, including the nation's first clinical-grade retroviral vector production line and internationally leading gene editing systems. As the first foreign-invested enterprise to benefit from the medical open pilot program, the group established the Shenzhen-Hong Kong Cell Valley, creating a dual-driven model of "healthcare + consumption." Shenzhen Cell Valley, serving as the production and R&D headquarters, provides full-process CRO/CDMO services, collaborating with over a hundred institutions to tackle critical industry challenges and empower industrial development.

    About Us
    About Us
    Company ProfileCell Valley Group was founded by a group of passionate and visionary Chinese scientists from the United States and Hong Kong. The founding team members come from world-renowned universities such as Harvard University, Cornell University, Columbia University, and the University of California, San Diego, possessing exceptional research capabilities and an international perspective. The cutting-edge research concepts, profound academic foundation, and strong innovation capabilities provided by these top universities have laid a solid foundation for the development of Cell Valley Gr...
    • 103
      public hospital
    • 7000
      square meters C+A'B+A' Cleanroom
    • 198
      Partner companies
    • 38
      technical patents
    更多

    Focusing on cell therapy • Leading the future of healthcare

    Shenzhen Cell Valley Group is a one-stop integrated outsourcing service provider specializing in the cell and gene therapy (CGT) industry in China. It is currently the only CRO/CDMO group company in China with GMP-compliant industrial-scale production capabilities for clinical-grade retroviral vectors.

    partner

    About Us
    Scan to follow our latest newsScan to follow our latest news
    Contact Us
    400-800-1266

    Working hours: Monday to Friday, 9:00-18:00

    Contact：Ms. Lai

    Email：laijiaqi@jdxinyu.com

    Address：No. 1, Rongtian Road, Jinsha Community, Kengzi Street, Pingshan District, Shenzhen, China (Hepure Biomedical Ecological Park)

    Bottom Navigation
    Shenzhen Cell Valley Biopharmaceutical Co., Ltd.​​ is a comprehensive one-stop outsourcing service provider in China focused on the cell and gene therapy industry. It is also one of the first CRO/CDMO companies in the country to possess GMP industrial production capabilities for clinical-grade retroviral vectors . The company is a major public technical service platform construction project for CRO/CDMO in Shenzhen and is included among the city's latest announced "20+8" strategic emerging industry projects.Shenzhen Cell Valley has the capability for standardized and industrialized production of GMP-grade cell products such as CAR-T cells. Its primary production lines include those for various cell products like CAR-T, CAR-NK, CAR-M, γδT, TIL, and TCR-T. Additionally, the company operates production lines for various viral vectors, including RVV, LVV, non-viral vectors, and AAV, as well as for cellular raw materials used in producing therapeutics such as exosomes, genetically engineered antibodies, cytokines, oncolytic viruses, and vaccines.
     Copyright 粤ICP备2024168379号 互联网药品信息服务资格证书：(粤)-非经营性-2022-0426  Technical Support：YouDian Software